When Drug Price Transparency Isn’t Enough

By KRISTINA SMITH & PHIYEN NGUYEN Policymakers and advocates often promote drug price transparency to lower costs and improve equity. While transparency is an important first step toward accountability and informed public budgeting, it does not guarantee affordable prices or fair access to medicines. Transparency Has Some Benefits Drug price transparency helps show how and…

Read More

A Perfect Storm is Brewing Within the U.S. Healthcare Workforce: Public Policy, Data, and AI Will Help Us Weather It

Weathering the storm will require a bold, multi-pronged approach encompassing legislative action and a data-informed approach that leverages AI technology to plan, recruit, and realign more efficient care models.   The post A Perfect Storm is Brewing Within the U.S. Healthcare Workforce: Public Policy, Data, and AI Will Help Us Weather It appeared first on MedCity…

Read More

Complaints About Gaps in Medicare Advantage Networks Are Common. Federal Enforcement Is Rare.

Along with the occasional aches and pains, growing older can bring surprise setbacks and serious diseases. Longtime relationships with doctors people trust often make even bad news more tolerable. Losing that support — especially during a health crisis — can be terrifying. That’s why little-known federal requirements are supposed to protect people with privately run…

Read More